News

Home/News
News 2017-06-21T13:15:59+00:00
June 1, 2017
TiGenix to present at the Jefferies 2017 Global Healthcare Conference in New York
<b>Leuven (BELGIUM) - June 1, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company </b><b>focused on exploiting the anti-inflammatory ...
June 1, 2017
OBI Pharma Announces Acquisition of TH-3424 from Threshold Pharmaceuticals
TAIPEI, Taiwan, June 1, 2017 /PRNewswire/ -- OBI Pharma, Inc., a Taiwan biopharma company (TPex:4174), announced today an agreement with Threshold Pharmaceuticals, Inc. (THLD) to ...
June 1, 2017
Ignyta to Present at Jefferies 2017 Global Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jonathan Lim, M.D., its Chairman and Chief Executive Officer, ...
June 1, 2017
BioDelivery Sciences to Present at the Jefferies 2017 Healthcare Conference and the William Blair 2017 Growth Stock Conference
RALEIGH, N.C., June 1, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer, will present at ...
June 1, 2017
Foamix Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
REHOVOT, Israel and BRIDGEWATER, New Jersey, June 1, 2017 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing ...
June 1, 2017
Achaogen Initiates C-Scape Clinical Development Program with Phase 1 Study of Orally-Administered Antibacterial Candidate
SOUTH SAN FRANCISCO, Calif., June 01, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
June 1, 2017
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
LIVONIA, Mich., June 01, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
June 1, 2017
Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis' Clinical Trials
SAN DIEGO, June 1, 2017 /PRNewswire/ -- Synthetic Genomics, Inc. and Advaxis, Inc. (ADXS) announced today that they have completed development and deployment of the ...
June 1, 2017
Arena Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference June 9th
SAN DIEGO, June 1, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that members of its senior management team will present a corporate update at the ...
June 1, 2017
Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., June 01, 2017 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (OCRX), today announced the dosing of the first ...
May 31, 2017
Albireo Announces Closing of $51.9 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares
BOSTON, May 30, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today ...
May 31, 2017
Gemphire Therapeutics Announces Departure of Its Chief Executive Officer Mina Sooch
LIVONIA, Mich., May 30, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP) announced today that Mina Sooch, President, CEO, and Director of the Company has ...
May 31, 2017
Aurinia to Participate in Late Breaking Oral Presentations at Two Upcoming Scientific Conferences
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (AUPH)(AUP.TO), a clinical stage biopharmaceutical company focused on the global immunology market, today announced that is has been selected ...
May 31, 2017
Addex Increases Issued Share Capital and Creates Treasury Shares
Geneva, Switzerland, 31 May 2017 - Addex Therapeutics (ADXN.SW) announced today that it has increased its capital from 13,454,553 to 15`384`988 through the issue of ...
May 31, 2017
TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure
Leuven (BELGIUM) - May 31, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory ...
May 31, 2017
Total number of shares and voting rights in Zealand at May 31, 2017
Copenhagen, May 31, 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers` Disclosure Obligations, Zealand issues announcements to state the ...
May 31, 2017
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
EMERYVILLE, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system ...
May 31, 2017
Catalyst Biosciences’ Factor IX Recommended for Orphan Drug Designation in Europe
SOUTH SAN FRANCISCO, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
May 30, 2017
Lysogene Completes Enrollment in First International Pivotal Observational Study in MPS IIIA
Lysogene (LYS.PA) (FR0013233475 – LYS), a leading, biopharmaceutical company pioneering gene therapy technologies to treat central nervous system diseases, today announced the completion of enrollment ...
May 30, 2017
Zealand increases its share capital as a consequence of exercise of employee warrants
Copenhagen, May 30, 2017 - Zealand Pharma ("Zealand") has increased its share capital by a nominal amount of DKK 5,000 divided into 5,000 new shares ...
Page 24 of 33